Allscripts Healthcare Solutions, Inc. MDRX is well-poised for growth in the coming quarters, courtesy of its strategic alliances over the past few months. A robust second-quarter 2022 performance and ...
LONDON/NEW YORK, June 9 (Reuters) - U.S. healthcare IT company Allscripts plans to buy rival Eclipsys in a $1.3 billion all-stock deal to capitalize on a huge influx of U.S. government funding for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results